Ohcanbohtosat - Muhammad Al‐Hajj

  • Čájehuvvo 1 - 9 / 9
Aiddostahte ozu
  1. 1
    Stem cells in normal breast development and breast cancer

    Stem cells in normal breast development and breast cancer Dahkki MS Wicha, Gabriela Dontu, Muhammad Al‐Hajj, MF Clarke

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Stem cells in normal breast development and breast cancer

    Stem cells in normal breast development and breast cancer Dahkki Gabriela Dontu, Muhammad Al‐Hajj, Wissam Abdallah, Michael F. Clarke, Max S. Wicha

    Almmustuhtton 2003
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Prospective identification of tumorigenic breast cancer cells

    Prospective identification of tumorigenic breast cancer cells Dahkki Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández, Sean J. Morrison, Michael F. Clarke

    Almmustuhtton 2003
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Phase 1 First-in-Human Study of AUTO2, the First Chimeric Antigen Receptor (CAR) T Cell Targeting APRIL for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

    Phase 1 First-in-Human Study of AUTO2, the First Chimeric Antigen Receptor (CAR) T Cell Targeting APRIL for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Dahkki Rakesh Popat, Sonja Zweegman, Jim Cavet, Kwee Yong, Lydia Lee, Jim Faulkner, Ekaterini Kotsopoulou, Muhammad Al‐Hajj, Simon Thomas, Shaun Cordoba, Martin Pulè, Virginie Cérec, Vijay Peddareddigari, Nushmia Z. Khokhar, Tobias Menne

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

    Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblas... Dahkki Persis Amrolia, Robert Wynn, Rachael Hough, Ajay Vora, Denise Bonney, Paul Veys, Robert Chiesa, Kanchan Rao, Liz Clark, Muhammad Al‐Hajj, Shaun Cordoba, Shimobi Onuoha, Ekaterini Kotsopoulou, Nushmia Z. Khokhar, Martin Pulè, Vijay Peddareddigari

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

    Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy Dahkki Lydia Lee, Wen Chean Lim, Daria Galas‐Filipowicz, Kent Fung, Julia M. Taylor, Dominic Patel, Zulaikha Akbar, Elena Alvarez Mediavilla, Patrycja Wawrzyniecka, Debarati Shome, Rogier M. Reijmers, Trillian Gregg, Leigh Wood, William Day, Virginie Cérec, Mathieu Ferrari, Simon Thomas, Shaun Cordoba, Shimobi Onuoha, Nushmia Z. Khokhar, Vijay Peddareddigari, Muhammad Al‐Hajj, Jim Cavet, Sonja Zweegman, Manuel Rodriguez‐Justo, Kwee Yong, Martin Pulè, Rakesh Popat

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling

    In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling Dahkki Peter G. Miller, Fátima Al‐Shahrour, Kimberly A. Hartwell, Lisa P. Chu, Marcus Järås, Rishi V. Puram, Alexandre Puissant, Kevin P. Callahan, John M. Ashton, Marie McConkey, Luke Poveromo, Glenn S. Cowley, Michael G. Kharas, Myriam Labelle, Sebastian Shterental, Joji Fujisaki, Lev Silberstein, Gabriela Alexe, Muhammad Al‐Hajj, Christopher A. Shelton, Scott A. Armstrong, David E. Root, David T. Scadden, Richard O. Hynes, Siddhartha Mukherjee, Kimberly Stegmaier, Craig T. Jordan, Benjamin L. Ebert

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

    CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial Dahkki Shaun Cordoba, Shimobi Onuoha, Simon Thomas, Daniela Soriano Pignataro, Rachael Hough, Sara Ghorashian, Ajay Vora, Denise Bonney, Paul Veys, Kanchan Rao, Giovanna Lucchini, Robert Chiesa, Jan Chu, Liz Clark, Mei Mei Fung, Koval Smith, Carlotta Peticone, Muhammad Al‐Hajj, Vania Baldan, Mathieu Ferrari, Saket Srivastava, Ram Jha, Frederick Arce Vargas, Kevin Duffy, William Day, Paul Virgo, Lucy Wheeler, Jeremy Hancock, Farzin Farzaneh, Sabine Domning, Yiyun Zhang, Nushmia Z. Khokhar, Vijay Peddareddigari, Robert Wynn, Martin Pulè, Persis Amrolia

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma

    Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma Dahkki Karin Straathof, Barry Flutter, Rebecca Wallace, Neha Jain, Thalia Loka, Sarita Depani, Gary Wright, Simon Thomas, Gordon Weng-Kit Cheung, Talia Gileadi, Sian Stafford, Evangelia Kokalaki, Jack Barton, Clare Marriott, Dyanne Rampling, Olumide Ogunbiyi, Ayse U. Akarca, Teresa Marafioti, Sarah Inglott, Kimberly Gilmour, Muhammad Al‐Hajj, William Day, Kieran McHugh, Lorenzo Biassoni, Natalie Sizer, Claire Barton, David Edwards, I. Dragoni, Julie Silvester, Karen Dyer, Stephanie Traub, Lily Elson, Sue Brook, Nigel Westwood, L Robson, Ami Bedi, Karen Howe, Ailish Barry, Catriona Duncan, Giuseppe Barone, Martin Pulè, John Anderson

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: